Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON35551Not yet recruiting
Randomised, open-label trial in hypertension (HTN) and pregnancy-induced hypertension (PIH) (2 arms), sponsored by University of British Columbia. Primary endpoint: Primary composite endpoint. Planned start Apr 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON35551.